2017/07/03 – Who is Charlie Gard, what is the mitochondrial disease he suffers from and why was there a legal battle? – UK Telegraph
Charlie is a 10-month old patient in intensive care at Great Ormond Street Hospital (GOSH) in London.
Doctors discovered he had a rare inherited disease – infantile onset encephalomyopathy mitochondrial DNA depletion syndrome (MDDS).
The condition causes progressive muscle weakness and brain damage.
His parents wanted to take him to the U.S. for some experimental therapy.
But doctors at GOSH concluded that the experimental treatment, which is not designed to be curative, would not improve Charlie’s quality of life.
Therefore, the matter goes to court. The UK court denied their request. The European court upheld the UK court decision.
They have raised over $2 million via GoFundMe. This has to be terrible for the family. No reports of this anywhere in the U.S.
President Trump has tweeted in as well…
This is what results from government controlled single payer health care. They make the decisions because they control the flow of money.